Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Mar 1;531(Pt 2):417-23.
doi: 10.1111/j.1469-7793.2001.0417i.x.

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

Affiliations

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

Y Kudo et al. J Physiol. .

Abstract

The physiological importance of L-tryptophan transport for placental indoleamine 2,3-dioxygenase-mediated degradation of L-tryptophan has been studied using human placental chorionic villous explants. L-Tryptophan influx into villous explants is supported exclusively by transport system L and is substantially inhibited by the L-system-specific substrate 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) and also by 1-methyl-tryptophan which is also an inhibitor of indoleamine 2,3-dioxygenase. L-Tryptophan influx is enhanced 2.3-fold following in vitro culture of the villous explant. Interferon-gamma, which increases villous explant indoleamine 2,3-dioxygenase expression, has no effect on L-tryptophan influx. In explants both BCH and 1-methyl-tryptophan inhibit indoleamine 2,3-dioxygenase-mediated L-tryptophan degradation. This also applies when L-tryptophan degradation has been stimulated by interferon-gamma. These findings show transport of L-tryptophan into the trophoblast to be a rate-limiting step for indoleamine 2,3-dioxygenase-mediated L-tryptophan degradation and therefore for the normal physiology of mammalian pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Time course of l-tryptophan influx into placental explants
Radioactive l-tryptophan content of explants of villous tissue was measured as a function of time over the period indicated. Medium contained 2 μml-[3H]tryptophan (2 μCi ml−1 or 74 KBq ml−1) in the presence or absence (choline) of sodium as described in Methods. •, sodium; ○, choline. Data represent the means ±s.d. of three separate experiments with triplicate assays from three different placentae.
Figure 2
Figure 2. Effect of BCH and 1-methyl-tryptophan and l-tryptophan on radioactive l-tryptophan influx into placental explants
l-Tryptophan influx over a 30 s period was measured in medium containing 2 μml-[3H]tryptophan (2 μCi ml−1 or 74 KBq ml−1) with indicated concentrations of unlabelled l-tryptophan (A) and BCH (BCH) or 1-methyl-tryptophan (B) in the absence (choline) of sodium as described in Methods. Data show carrier-mediated influx rate defined by subtracting the diffusional component from the total influx. The diffusional component was determined by measuring the influx of l-[3H]tryptophan in the presence of 20 mm unlabelled l-tryptophan. The lines were fitted using least-square regression analysis. Each point represents the mean ±s.d. of one representative of three separate experiments from three different placentae with five replicate assays. •, l-tryptophan (A) or BCH (B); ○, 1-methyl-tryptophan.
Figure 3
Figure 3. Effect of in vitro culture on l-tryptophan influx in placental explants
l-Tryptophan flux into either fresh or cultured (with or without 1000 units ml−1 interferon-γ (IFN)) explant of villous tissue over a 30 s period was measured in medium containing 2 μml-[3H]tryptophan (2 μCi ml−1 or 74 KBq ml−1) with or without unlabelled amino acid (2 mm for l-tryptophan, BCH or 1-methyl-tryptophan, final concentration) in the presence or absence (choline) of sodium as described in Methods. Data show carrier-mediated influx defined by subtracting the diffusional component from the total influx (in either the presence or absence of sodium). The diffusional component was determined by measuring the influx of l-[3H]tryptophan in the presence of 20 mm unlabelled l-tryptophan. Data represent the means ±s.d. of three separate experiments with triplicate assays from three different placentae. The mediated BCH-sensitive fluxes in fresh and in cultured tissue with or without interferon-γ are, respectively, 8.56 ± 1.58, 19.98 ± 2.20 and 19.64 ± 1.85 pmol (mg protein)−1 (30 s)−1. The rate following culture is significantly greater than for fresh samples (P value was less than 0.01 in both control and interferon-γ group).
Figure 4
Figure 4. Effect of 1-methyl-tryptophan on l-tryptophan catabolism by indoleamine 2,3-dioxygenase in placental explants
Villous explants were cultured with 1000 units ml−1 interferon-γ and/or 2 mm 1-methyl-tryptophan or vehicle (control) for the time indicated. Concentrations of l-tryptophan (A) and l-kynurenine (B) in the conditioned medium were analysed by HPLC and indoleamine 2,3-dioxygenase activity (C) in the tissue extract was determined colorimetrically as described in Methods. •, control; ○, interferon-γ; ▾, 1-methyl-tryptophan; ▿, interferon-γ and 1-methyl-tryptophan. Data represent the means ±s.d. of three separate experiments with triplicate assays from three different placentae.
Figure 5
Figure 5. Effect of BCH on l-tryptophan catabolism by indoleamine 2,3-dioxygenase in placental explants
Villous explants were cultured with 1000 units ml−1 interferon-γ and/or 2 mm BCH or vehicle (control) for the time indicated. Concentrations of l-tryptophan (A) and l-kynurenine (B) in the conditioned medium were analysed by HPLC and indoleamine 2,3-dioxygenase activity (C) in the tissue extract was determined colorimetrically as described in Methods. •, control; ○, interferon-γ; ▾, BCH; ▿, interferon-γ and BCH. Data represent the means ±s.d. of three separate experiments with triplicate assays from three different placentae.

Similar articles

Cited by

References

    1. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Procceedings of the National Academy of Sciences of the USA. 1999;96:12079–12084. - PMC - PubMed
    1. Cetin I, Corbetta C, Sereni LP, Marconi AM, Boettizz P, Pardi G, Battaglia FC. Umbilical amino acid concentrations in normal and growth-retarded fetuses sampled in utero by cordocentesis. American Journal of Obstetrics and Gynecology. 1990;162:253–261. - PubMed
    1. Christensen HN, Handlogten ME, Lam I, Tager HS, Zand R. A bicyclic amino acid to improve discriminations among transport systems. Journal of Biological Chemistry. 1969;244:1510–1520. - PubMed
    1. Devés R, Boyd CAR. Surface antigen CD98(4F2): not a single membrane protein, but a family of proteins with multiple functions. Journal of Membrane Biology. 2000;173:165–177. - PubMed
    1. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) Journal of Biological Chemistry. 1998;273:23629–23632. - PubMed

Publication types

LinkOut - more resources